U.S. Market Community
Our community narratives are driven by numbers and valuation.
U.S. Investing Ideas
The Oncology Anchor: Why Merck’s 46% Discount Defies the Keytruda Cliff
Merck’s 2026 narrative is a high-stakes drama centered on Keytruda , the world’s top-selling cancer drug. For years, the market has treated Merck like a "one-trick pony" due to the looming 2028 "patent cliff," where Keytruda will lose its legal protection and face generic competition.Read more
Palantir: Redefining Enterprise Software for the AI Era
Company Overview Founded in 2003 by Peter Thiel, Alex Karp, Stephen Cohen, Joe Lonsdale, and Nathan Gettings, Palantir Technologies emerged from the shared vision of transforming how data could be used to solve complex problems. Peter Thiel, a co-founder of PayPal and a prominent venture capitalist, brought his knack for identifying transformative opportunities.Read more
Microsoft - A Fundamental and Historical Valuation
☁️ Business Overview Total: 12/17 +2 ✅✅ Projected Operating Margin: 50.69% +1 ✅ Projected 5-Year Revenue CAGR: 14.64% +2 ✅✅ Last 5-Year ROIC: 28.78% +1 ✅ Estimated Cost of Capital: 10.35% (lower than ROIC) +1 ✅ Last 5-Year Shares Outstanding CAGR: -0.50% +1 ✅ Projected 5-Year EPS CAGR: 18.36% +0 ⚠️ Projected 5-Year Dividend CAGR: 6.32% +2 ✅✅ Estimated Debt Rating: Aaa +2 ✅✅ Morningstar Moat: Wide +0 ⚠️ Morningstar Uncertainty: Medium Microsoft show its competitive advantages and pricing power through its stellar margins and higher revenue and EPS growth. This is reflected in its Morningstar Wide Moat rating.Read more
Hims & Hers Health aims for three dimensional revenue expansion
In a nutshell: Hims & Hers’ recent investments are overlooked by investors, but they signal strongly revenue growth is not slowing down. The Starting Point Some analysts have low estimates for future revenue growth (approx.Read more
The Architect of Sovereignty: Palantir’s Premium Paradox at $149
Palantir’s journey into 2026 is the story of a "Black Box" defense contractor that successfully transformed into the central nervous system of the global enterprise. Once whispered about in the halls of intelligence agencies, the company’s Artificial Intelligence Platform (AIP) has moved from secretive government basements to the front lines of heavy industry and sovereign AI alliances.Read more
Pfizer is about resilience and dividend yield
O Futuro da Pfizer (PFE): Uma Narrativa de Transição e Resiliência No final de 2025, a Pfizer Inc. (PFE) encontra-se em um momento pivotal de sua história.Read more
Apple Inc. (AAPL) — Durable Compounder With Services-Led Earnings Upside
Investment thesis Apple is a mature but exceptionally durable compounder. While iPhone unit growth is structurally limited, Apple’s ecosystem, pricing power, and expanding high-margin Services segment support steady revenue growth and faster earnings and free cash flow growth.Read more
Alexandria Real Estate Equities Is Going to Transform With a 27.2% Future Pe Ratio
Core Fundamental Data Alexandria Real Estate Equities (NYSE: ARE) is a specialized life science REIT with a highly concentrated portfolio of laboratory and office real estate. As of September 30, 2025, total shareholders’ equity amounted to $16,639 million.Read more
Hotel101 Global: A Scalable Hospitality Platform Built to Compound
Exceptional investments are often hiding behind familiar labels. Hotel101 Global Holdings may appear, at first glance, to be just another hotel company.Read more
